论文部分内容阅读
目的探讨改良右半结肠切除术治疗结肠癌的临床效果,为临床推广做出指导。方法选择本院自2008年1月~2010年6月收治的74例需手术治疗的结肠癌患者为研究对象,根据患者本人及其家属的意愿,按照不同的手术方式分为两组,对照组给予常规手术治疗,治疗组给予改良右半结肠切除术治疗,比较两组患者的临床治疗效果。结果①治疗组手术各项指标均优于对照组,差异具有统计学意义(P<0.05);②治疗组患者不良反应发生率为10.26%(4/39),明显低于对照组22.86%(8/35),差异具有统计学意义(P<0.05);③治疗组患者的死亡率为5.13%(2/39),复发转移率为12.82%(5/39),明显低于对照组死亡率17.14%(6/35),复发转移率31.43%(11/35),差异具有统计学意义(P<0.05)。结论改良右半结肠切除术治疗结肠癌的临床效果显著,值得广泛推广。
Objective To explore the clinical effect of modified right hemicolectomy for colon cancer and provide guidance for clinical promotion. Methods Seventy-four patients with colon cancer undergoing surgical treatment from January 2008 to June 2010 were selected as the study subjects. According to the wishes of the patients themselves and their families, the patients were divided into two groups according to different surgical methods. Given conventional surgical treatment, the treatment group received an improved right hemicolectomy and compared the clinical efficacy of the two groups of patients. Results 1 The indexes of operation in the treatment group were better than those in the control group (P<0.05). The incidence of adverse reactions in the treatment group was 10.26% (4/39), which was significantly lower than the control group (22.86%). 8/35), the difference was statistically significant (P<0.05); 3 The mortality rate of the treatment group was 5.13% (2/39), and the recurrence and metastasis rate was 12.82% (5/39), which was significantly lower than the control group. The rate was 17.14% (6/35). The recurrence metastasis rate was 31.43% (11/35). The difference was statistically significant (P<0.05). Conclusion The improved right colon resection for colon cancer has significant clinical effects and is worthy of extensive promotion.